1. The present investigation was undertaken to study the kinetics of 9hnTc-labelled diethylenetriaminepenta-acetate (DTPA) as compared with inulin and "Cr-labelled ethylenediaminetetraacetate (EDTA).
Introduction
The renal clearance of inulii obtained during constant intravenous infusion has long been accepted as the reference measure of the glomerular filtration rate (GFR). This technique, however, involves a somewhat complicated chemical analysis and a quantitative urine collection during the clearance periods. In order to circumvent these difficulties, a plasma clearance technique has been invented to evaluate GFR. This method consists of an intravenous bolus injection of a radioactively labelled tracer, e .g . %-labelled ethylenediaminetetraacetate (EDTA), and collection of venous blood samples during the next 5 h [l]. Urine collection is not needed. The plasma clearance of %-EDTA agrees well with the renal clearance of inulin except in patients with severely decreased renal function [ 1, 2] .
In recent years there has been a growing interest in assessment of single kidney function by renography with the y-camera directly followed by measurement of GFR using the plasma clearance technique. Due to its radiophysical properties %r-EDTA is not suitable for studies using a y-camera. 99mTc-labelled diethylenetriaminepenta-acetate (DTPA) is well suited for this purpose as well as for estimation of GFR using the plasma clearance technique [3] .
In a previous study we compared the plasma clearances of four different wmT~-DTPA preparations with that of "Cr-EDTA using a single-injection technique 131. Only one preparation yielded results identical to those obtained with "Cr-EDTA. In order t o further elucidate the use of this w m T~-DTPA preparation for estimation of GFR the present study compares the plasma clearance, renal clearance and volume of distribution of wmT~-DTPA with those of 'lCr-EDTA and inulin.
Methods

Subjects
Twenty patients, ten females and ten males, aged 49 to 78 years (median 67 years), were studied. All had been unilaterally nephrectomized as treatment for nephrolithiasis (eight patients), renal carcinoma (six patients) or renovascular hypertension (six patients). None had diabetes mellitus, oedema, ascites or lower urinary tract obstruction. The patients were in steady state concerning body weight and renal function as judged by repeated determination of serum creatinine.
Protocol
After an overnight fast, the patients were given 300 ml of water/h throughout the study. The patients rested supine, but were allowed to stand up during voiding. A polyethylene catheter was inserted into a cubital vein in both arms. Depending on GFR and the body weight 35-55 ml of a 10% inulin solution (Laevosan Gesellschaft, Austria) was injected from t = -1 to t = 1 min. At t = 2 m i n 54pCi (2MBq) of 99mTc-DTF'A (CIS, France) per kg body weight and 1OOpCi (3.7 MBq) of 'lCr-EDTA (Amersham, U.K.) were injected simultaneously. The volume of the radioactive tracers varied from 1.5 t o 2.5 ml. The catheter was flushed through with 20 in1 of a 0.9% NaCl solution. The exact volume of tracer injected was calculated by the weight loss of the syringe divided by the specific gravity of the solution. For inulin a specific gravity of 1.044 g/ml was used. Blood samples were drawn from the contralateral arm at 5, 10, 20,40,60,90, 120, 150, 180, 210, 243, 270 and 300 min. The urine was collected and time of voiding noted. Urine and plasma blanks were obtained from samples taken before the injection of inulin. Blood glucose was measured at 0, 120 and 240 min. Inulin in plasma and urine was determined spectrophotometrically after deproteinization [4] . The radioisotope activity was counted in plasma samples of 2 ml with a well-crystal scintillation detector to a statistical accuracy of 1%. The time-plasma concentration curves were described as a sum of three exponential functions, with the peeling-off technique [I] . The smallest rate constant (final slope) was calculated over the period from 150 to 300 min.
In each urine collection period the renal clearance (C(i),) was calculated according to the equation:
where U denotes urine concentration, V volume of urine, P(t) plasma concentration and i the period number. Delay in the urinary tract dead space was taken to be 4.5 min [5] . The mean transit time from the brachial artery to the cubital vein was taken to be 1.6 min [6] . Consequently, the ti values were subtracted 2.9 min [eqn. (l)]. The renal clearance (C,) was finally calculated as the mean of the renal clearances obtained in the interval from 60 to 300 min after the injection.
The total plasma clearance (C,) was calculated as the ratio between the injected amount of tracer (Qo) and the total area under the plasma concentration curve (P(t)): The plasma concentration in the outlet is ideally the arterial concentration. Although the arterial and venous concentrations at a given time are not identical owing to extraction of tracer in the kidney, the and values will be identical. Thus the plasma concentration in a vein can be used. The concentration of inulin is measured spectrophotometrically in plasma water. However, for protein precipitation the plasma samples are diluted 10-fold reducing the relative volume of the proteins proportionally. Thus the concentration of inulin measured will overestimate the plasma concentration by only about 0.5%. This has not been corrected for.
Statistics
All comparisons were made with the Wilcoxon test for paired differences which were considered significant if a 2P value less than 0.05 was obtained.
Results
Seventy-one renal clearance periods were obtained in 20 patients. For each patient the renal clearance was calculated as the mean of two to five clearance periods (median four). The diuresis during the clearance periods varied from 1.9 to 9.3 ml/min (median 4.7).
The renal clearance, plasma clearance, final slope, volume of distribution (as % body weight) and total amount of tracer excreted during 5 h (as % of injected amount) for all three tracers are shown in Table 1 .
The renal clearances of all three tracers are shown in Fig. 1 . The average clearance ratio 99mTc-DTPA to inulin was 0.97; the average clearance ratio 99mT~-DTPA to "Cr-EDTA was 1.02.
The plasma clearances of all three tracers are shown in Fig. 2 . The plasma clearance of all three tracers was significantly greater than the simultaneously measured renal clearance: on average for 99mT~-DTPA 5.7 ml/min, for "Cr-EDTA 6.0 ml/min and for inulin 8.1 ml/min (Fig. 3) . The difference between -Tc-DTPA and %-EDTA was not significant.
The final slope for inulin was significantly greater than that for -Tc-DTPA which was greater than that for "Cr-EDTA. The volume of distribution of inulin was exceeded that of "Cr-EDTA. This variable for smaller than that of -Tc-DTPA.
The volume of inulin could only be measured in 12 patients as in distribution of wmT~-DTPA did not differ from eight patients the inulin concentration in the first that of "Cr-EDTA.
urine voided after the injection was too high t o be The total amount of inulin excreted by the measured spectrophotometrically.
kidney during the 5 h in % of the dose admini- Fig. 4 shows the plasma clearance of *"' Tcstered exceeded that of -Tc-DTPA which again DTPA compared with the simultaneously The blood glucose was within normal range in all patients and varied on average by 0.5 mmol/l during the study.
Discussion
The renal clearance of the tracers was measured during a period of decreasing plasma concentration. In this situation the concentration of tracer in a peripheral vein will exceed that in an artery [7] . In four normal subjects the venous concentration of inulin was 7.4% higher than the arterial after a single injection [8] . Thus a renal clearance calculated from venous plasma concentration will underestimate the true clearance. However, all our patients had decreased renal function with GFR values from 11 to 76 ml/min, so the difference between the venous and the arterial concentration of tracer was probably lower than 7.4%. Furthermore we made a correction for the transport delay from the artery to the vein. Therefore we consider our renal clearance values to be underestimated We found the ratio between the renal clearance of -Tc-DTPA and inulin to be 0.97. The difference between the two radioactively labelled tracers was not significant. This agrees well with ma~imally by 2-3%. the literature where the clearance ratio 51Cr-EDTA to inulin is found to vary from 0.85 to 1.01 during studies at constant infusion [9-191. The reason why the renal clearance of 99mT~-DTPA and "Cr-EDTA is less than that of inulin is not obvious. Several factors may decrease the renal clearance of the radioactively labelled tracers. However, binding to plasma proteins is less than 0.5% and binding to erythrocytes seems not to take place [3, 9, 20, 211 . Reabsorption in tubules is unlikely since the renal clearance is independent of the concentration in plasma and the diuresis [22, 231 . Less than 1% of %-EDTA has been found dissociated in viva [9] . The 99mTc-DTPA preparation has a labelling yield of over 99%. A greater amount of free 99"Tc-pertechnetate is unlikely since the renal clearance of 99mT~-DTPA and 51Cr-EDTA did not differ.
The plasma clearance has been measured according to eqn. (2) . If a final slope has not been reached within the time of examination the total area under the plasma curve will be underestimated and the plasma clearance overestimated. For all tracers we found that the plasma clearance overestimated the renal clearance, but to a greater degree for inulin. This supports the view that a final slope has not been reached, particularly not for inulin, which has a much smaller diffusion coefficient in water than the radioactively labelled tracers [24] . In agreement with our earlier investigations we found the plasma clearance of 99mT~-DTPA to equal that of "Cr-EDTA [3] . The final slope for 99mT~-DTPA was slightly higher than that of "Cr-EDTA. This is still in accordance with our earlier studies in patients with GFR values comparable with those studied here [3] . Hilson et al. [25] have compared the plasma clearance of 99mTc-DTPA with that of "Cr-EDTA in 45 patients using a single-injection, single-exponential method. The clearance of 99mTc-DTPA was about 11% lower than that of "Cr-EDTA. This agrees with our earlier investigation using the same technique and the same DTPA preparation (Diagnostic Isotopes, Bloomfield) [3] .
We found a close correlation between plasma clearance of 99mT~-DTPA and renal clearance of inulin. The plasma clearance of 9 9 m~~-~~~ overestimated the renal clearance of inulin by 3.5 ml/min on average.
The volume of distribution of inulin was less than that of 99mTc-DTPA and "Cr-EDTA. This might be explained by the fact that inulin is a bigger molecule with an elongated configuration [26] . The volume of distribution of inulin is usually measured with a constant-infusion technique. However, the volume of distribution we found agrees well with the literature [27] .
During the study, the relative amount of inulin excreted in the urine exceeded that of 99mTc-DTPA, which again exceeded that of 51Cr-EDTA. This can simply be explained by the differences in renal clearance and volume of distribution of the tracers.
In conclusion, the present study has shown small differences without clinical relevance in the kinetics of 99mTc-DTPA and 'lCr-EDTA in patients with decreased renal function. Therefore the two radioactively labelled tracers can replace each other in assessment of GFR.
The renal clearance of 99mT~-DTPA was on average 3% smaller than that of inulin. However, the plasma clearance of 99mTc-DTPA after a bolus injection correlated well with the renal clearance of inulin. This justifies the use of the singleinjection technique in assessment of GFR.
